A Phase 1/2a Study of CDK-003 in Patients With Cutaneous T-Cell Lymphoma (CTCL).
Clinical trial NCT05156229 · TERMINATED
Trial details
- NCT number
- NCT05156229
- Sponsor
- Codiak BioSciences
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-06
- Primary completion
- 2022-08-24
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.